PSG.DEライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 00:36):

Stats
本日の出来高	179.00
平均出来高	516.00
時価総額	266.18M
EPS	€0 ( 2024-04-07 )
次の収益日	( €0 ) 2024-06-26
Last Dividend	€0.490 ( 2023-06-29 )
Next Dividend	€0 ( N/A )
P/E	17.76
ATR14	€0 (0.00%)

PharmaSGP Holding SE 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

PharmaSGP Holding SE 財務諸表

Annual	2022
収益:	€85.82M
総利益:	€76.79M (89.48 %)
EPS:	€1.000

FY	2022
収益:	€85.82M
総利益:	€76.79M (89.48 %)
EPS:	€1.000

Financial Reports:

No articles found.

PharmaSGP Holding SE Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€0.490 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

PharmaSGP Holding SE Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.91 - Stable (1.77%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.450	2022-06-16
Last Dividend	€0.490	2023-06-29
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	€0.940	--
Avg. Dividend % Per Year	0.00%	--
Score	3	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.91
Div. Directional Score	8.25	--

Next Divdend (Est)
(2025-03-31)

€0.393 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.00

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SDF.DE	Ex Dividend Junior	2023-05-11	Annually	0.00%
CEK.DE	No Dividend Player	2023-11-06	Sporadic	0.00%
KRN.DE	Ex Dividend Knight	2023-05-24	Annually	0.00%
TTK.DE	Ex Dividend Junior	2023-05-25	Annually	0.00%
DWD.DE	Ex Dividend Junior	2023-07-28	Quarterly	0.00%
MZX.DE	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
8TRA.DE	Ex Dividend Junior	2023-06-02	Annually	0.00%
XGR2.DE	Ex Dividend Junior	2023-06-08	Annually	0.00%
FPMB.DE	Ex Dividend King	2023-10-12	Quarterly	0.00%
PFE.DE	Ex Dividend Knight	2023-07-27	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.154	1.500	6.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.114	1.200	6.20	7.44	[0 - 0.3]
returnOnEquityTTM	0.451	1.500	6.10	9.15	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.56	0.800	2.21	1.766	[1 - 3]
quickRatioTTM	2.05	0.800	2.66	2.13	[0.8 - 2.5]
cashRatioTTM	1.546	1.500	2.52	3.78	[0.2 - 2]
debtRatioTTM	0.00766	-1.500	9.87	-10.00	[0 - 0.6]
interestCoverageTTM	5.89	1.000	8.93	8.93	[3 - 30]
operatingCashFlowPerShareTTM	2.18	2.00	9.27	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.12	2.00	8.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0275	-1.500	9.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.906	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.246	1.000	7.08	7.08	[0.1 - 0.6]
cashFlowToDebtRatioTTM	25.94	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.742	0.800	8.39	6.71	[0.5 - 2]
Total Score				11.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.76	1.000	8.31	0	[1 - 100]
returnOnEquityTTM	0.451	2.50	7.49	9.15	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.12	2.00	9.29	10.00	[0 - 30]
dividendYielPercentageTTM	2.21	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.18	2.00	9.27	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.268	1.000	5.81	0	[0.1 - 0.5]
Total Score				4.91

PharmaSGP Holding SE

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.